BIG
ANIK icon

Brooklyn Investment Group’s Anika Therapeutics ANIK Stock Holding History

Brooklyn Investment Group’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,990
Closed -$118K – 1502
2025
Q3 		$118K Buy
10,990
+4,042
+58% +$38.6K 0.02% 636
2025
Q2 		$73.5K Buy
+6,948
New +$87.7K 0.01% 1124

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brooklyn Investment Group's ANIK Position: Q4 2025 in Review

Brooklyn Investment Group sold out of Anika Therapeutics (ANIK) in Q4 2025, closing a stake of 10,990 shares — an estimated $118K sold.

Brooklyn Investment Group first reported a position in ANIK in Q2 2025 and held it in 2 quarters. The position peaked at $118K in Q3 2025. 126 funds tracked by Wall St. Rank hold ANIK as of Q4 2025.

  • Brooklyn Investment Group reported no remaining Anika Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 10,990 Anika Therapeutics shares in Q4 2025, an estimated $118K.
  • Brooklyn Investment Group first reported a position in Anika Therapeutics in Q2 2025 and held it in 2 quarters.
  • Brooklyn Investment Group's Anika Therapeutics position peaked at $118K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2025.

Based on Brooklyn Investment Group's 13F filing for Q4 2025, filed 12 Feb 2026.